CapsoVision Stock Soars 64.29% Post-IPO

On July 3, 2025, CapsoVision's stock surged by 64.29% in pre-market trading, marking a significant rise in its share price.

CapsoVision, a medical technology company focused on the GI tract, successfully priced its initial public offering (IPO) at $5 per share. The company offered 5.5 million shares of common stock, which began trading on the Nasdaq Capital Market on July 2, 2025, under the ticker symbol "CV." The IPO was initially planned to offer 5.25 million shares but was upsized to 5.5 million shares at the time of pricing. This move allowed CapsoVision to raise $27.5 million, providing the company with substantial capital to support its growth and development in the medical technology sector.